Overexpression of FOXM1 and ERBB2 lead to genomic instability and uncontrolled cell division and malignancy, which are associated with poor prognosis in various cancerous lesions including breast cancers [50, 51]. The gene discussed is ERBB2; the disease is breast carcinoma.